Biomage - About the company
Biomage is an acquired company based in Glasgow (United Kingdom), founded in 2019. It operates as a Provider of a cloud-based cell and genomic sequence analysis platform for researchers. Biomage has raised $1.51M in funding from IndieBio, with last known valuation of £*****. The company has 506 active competitors, including 78 funded and 37 that have exited. Its top competitors include companies like DNAnexus, Fabric Genomics and Twin Strand Bio.
Company Details
Provider of a cloud-based cell and genomic sequence analysis platform for researchers. The company has developed a platform that allows researchers to analyses single-cell data. It has tools that provide analytical insights for data integration, sequencing, bioimaging, and more. The tool shows a graphical representation of cell distribution, cellular contents, and other sequencing data. It has data visualization, data integration and bioimage formation tools.
- Website
- www.biomage.net/
- Social
- Email ID
- *****@biomage.net
Key Metrics
Founded Year
2019
Location
Glasgow, United Kingdom
Stage
Acquired
Total Funding
$1.51M in 3 rounds
Latest Funding Round
Last Known Valuation
£***** as on Jan 01, 2021
Ranked
61st among 506 active competitors
Employee Count
1 as on Aug 31, 2026
Exit Details
Acquired by Parse Biosciences (Jan 16, 2024)
Legal entities associated with Biomage
Biomage is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
BIOMAGE LTD CIN: SC629589 , United Kingdom, Active | May 06, 2019 | - | 4 (As on May 31, 2024) |
Biomage's acquisition details
Biomage got acquired by Parse Biosciences on Jan 16, 2024.
Click here to take a look at Biomage's acquisition in detail
Sign up to download Biomage's company profile
Biomage's funding and investors
Biomage has raised a total funding of $1.51M over 3 rounds. Its first funding round was on Apr 29, 2020. Biomage has 5 institutional investors and 2 angel investors.
Here is the list of recent funding rounds of Biomage:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jan 01, 2021 | 5527124 | Seed | 9277486 | 6376207 | 9564248 | 5911559 |
Oct 27, 2020 | 3058041 | Seed | 8808682 | 2235034 | 3754234 | 5001300 |
Apr 29, 2020 | 5439027 | Seed | 2685832 | 4499549 | 8748431 | 2133727 |
Access funding benchmarks and valuations. Sign up today!View details of Biomage's funding rounds and investors
Biomage's founders and board of directors
Founder? Claim ProfileBiomage's employee count trend
Biomage has 1 employees as of Aug 26. Here is Biomage's employee count trend over the years:
Uncover Biomage's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Biomage's Competitors and alternates
Top competitors of Biomage include DNAnexus, Fabric Genomics and Twin Strand Bio. Here is the list of Top 10 competitors of Biomage, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  DNAnexus 2009, Mountain View (United States), Series H | Provider of cloud-based genome informatics & data management platform | $473M | 71/100 | |
2nd | Fabric Genomics 2009, Oakland (United States), Acquired | AI-based disease diagnosis and genomic analysis tool for providers | $32.8M | 67/100 | |
3rd |  Twin Strand Bio 2015, Seattle (United States), Series B | Developer of DNA sequencing technology to identify genomic mutations | $84M | 66/100 | |
4th |  Deep Genomics 2014, Toronto (Canada), Series C | AI-powered platform for RNA biology to accelerate genetic therapy discovery | $238M | 62/100 | |
5th | Hexagon Bio 2017, Menlo Park (United States), Series B | Provider of bioinformatics tools for the analysis of microbial genomic sequencing data | $206M | 62/100 | |
6th | BC Platforms 1997, Zurich (Switzerland), Series D | Provider of a platforms for genomic data analysis and management | $47.1M | 58/100 | |
7th | Genomenon 2014, Ann Arbor (United States), Series C | Provider of software, data, and services for genomic information analysis | $42.9M | 57/100 | |
8th |  Broken String Biosciences 2020, Cambridge (United Kingdom), Series A | Developer of biopharmaceutical products & cell therapies by using genome sequencing data | $15M | 55/100 | |
9th | Provider of gene biobanking database and services for research purposes | $45M | 54/100 | ||
10th |  OutSee United Kingdom, Seed | Developer of an artificial intelligence engine for predictive genomics | $5.79M | 54/100 | |
61st |  Biomage 2019, Glasgow (United Kingdom), Acquired | Provider of a cloud-based cell and genomic sequence analysis platform for researchers | $1.51M | 37/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Biomage's competitors? Click here to see the top ones
Biomage's Investments and acquisitions
Biomage has made no investments or acquisitions yet.
Reports related to Biomage
Here is the latest report on Biomage's sector:
News related to Biomage
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Biomage
Explore our recently published companies
- Image Unlimited - Boston based, 2006 founded, Public company
- Pain Free - 1949 founded, Unfunded company
- Wyndham Grand Istanbul - Istanbul based, 2013 founded, Unfunded company
- Forte - San Francisco based, Unfunded company
- Muller's - Egypt based, 2017 founded, Unfunded company
- Wise Roofing San Diego - San Diego based, Unfunded company
